Century Therapeutics to Participate in Upcoming Investor Conferences in March
Century Therapeutics (NASDAQ: IPSC) will participate in two investor conferences in March 2026 with scheduled fireside chats: TD Cowen on March 4, 2026 at 9:50 a.m. ET in Boston and Leerink Partners on March 10, 2026 at 4:20 p.m. ET in Miami.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Century Therapeutics (NASDAQ: IPSC) will participate in two investor conferences in March 2026 with scheduled fireside chats: TD Cowen on March 4, 2026 at 9:50 a.m. ET in Boston and Leerink Partners on March 10, 2026 at 4:20 p.m. ET in Miami.
A live webcast will be available on Century's Investors page and archived replays will remain available for at least 30 days.
Details
News Market Reaction – IPSC
On Feb 25, the day this news came out, IPSC closed 2.35% above the previous close.
Data tracked by StockTitan Argus for the Feb 25 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PHILADELPHIA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes, and cancer, today announced that the company will participate in the following upcoming investor conferences in March:
- TD Cowen 46th Annual Health Care Conference: Fireside chat at 9:50 a.m. ET on Wednesday, March 4, 2026, in Boston, MA.
- Leerink Partners Global Healthcare Conference: Fireside chat at 4:20 p.m. ET on Tuesday, March 10, 2026, in Miami, FL.
A live webcast of the presentations will be available on the Investors page of Century’s website at www.centurytx.com. Archived replays will be available for at least 30 days.
About Century Therapeutics
Century Therapeutics (NASDAQ: IPSC) is a biotechnology company advancing a pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies with the potential to meaningfully address autoimmune diseases, including type 1 diabetes, and cancer. The company’s therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies which will ultimately advance the course of care. For more information on Century Therapeutics, please visit www.centurytx.com and connect with us on LinkedIn.
For More Information:
Century Therapeutics
Douglas Carr
Senior Vice President, Finance
investor.relations@centurytx.com
JPA Health
Sarah McCabe
smccabe@jpa.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.